Previous Page  22 / 39 Next Page
Information
Show Menu
Previous Page 22 / 39 Next Page
Page Background

Volume 4

Nano Research & Applications

ISSN: 2471-9838

Page 81

JOINT EVENT

August 16-18, 2018 | Dublin, Ireland

&

12

th

Edition of International Conference on

Nanopharmaceutics and Advanced Drug Delivery

25

th

Nano Congress for

Future Advancements

Nano Congress 2018

&

Nano Drug Delivery 2018

August 16-18, 2018

Cancer nanotechnology: Gold nanostructures as a platform for combinational therapy in future cancer

therapeutics

Devika Chithrani

University of Victoria, Canada

T

he field of nanotechnology is currently undergoing explosive development on many fronts. The technology is expected

to generate innovations and play a critical role in cancer therapeutics. Among other nanoparticle (NP) systems, there has

been tremendous progress made in the use of gold nanostructures in cancer therapeutics. In treating cancer, radiation therapy

and chemotherapy remain the most widely used treatment options and recent developments in cancer research show that the

incorporation of GNPs into these protocols has enhanced tumor cell killing. These nanostructures further provide strategies

for better loading, targeting, and controlling the release of drugs to minimize the side effects of highly toxic anticancer drugs

used in chemotherapy and photodynamic therapy. In addition, the heat generation capability of gold nanostructures upon

exposure to UV or near infrared light is being used to damage tumor cells locally in photothermal therapy. Hence, gold

nanostructures provide a versatile platform to integrate many therapeutic options leading to effective combinational therapy

in the fight against cancer. In this presentation, the recent progress in the development of gold-based nanostructures towards

improved therapeutics will be discussed. A multifunctional platform based on gold nanostructures with targeting ligands,

therapeutic molecules, and imaging contrast agents, holds an array of promising directions for cancer research.

devikac@uvic.ca

Nano Res Appl 2018, Volume 4

DOI: 10.21767/2471-9838-C3-015